rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2005-1-26
|
pubmed:abstractText |
Up to one half of depressed patients have partial or no response to antidepressant monotherapy. This multicenter, placebo-controlled study evaluated the efficacy of modafinil augmentation in major depressive disorder (MDD) patients with fatigue and excessive sleepiness despite selective serotonin reuptake inhibitor (SSRI) monotherapy.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0160-6689
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
85-93
|
pubmed:dateRevised |
2007-1-19
|
pubmed:meshHeading |
pubmed-meshheading:15669893-Adolescent,
pubmed-meshheading:15669893-Adult,
pubmed-meshheading:15669893-Aged,
pubmed-meshheading:15669893-Benzhydryl Compounds,
pubmed-meshheading:15669893-Central Nervous System Stimulants,
pubmed-meshheading:15669893-Depressive Disorder, Major,
pubmed-meshheading:15669893-Drug Therapy, Combination,
pubmed-meshheading:15669893-Fatigue,
pubmed-meshheading:15669893-Female,
pubmed-meshheading:15669893-Humans,
pubmed-meshheading:15669893-Male,
pubmed-meshheading:15669893-Middle Aged,
pubmed-meshheading:15669893-Placebos,
pubmed-meshheading:15669893-Psychiatric Status Rating Scales,
pubmed-meshheading:15669893-Serotonin Uptake Inhibitors,
pubmed-meshheading:15669893-Sleep Disorders,
pubmed-meshheading:15669893-Treatment Outcome
|
pubmed:year |
2005
|
pubmed:articleTitle |
A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
|
pubmed:affiliation |
Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA. MFava@Partners.org
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|